Purchase Order 75N90019P00528
Award Date
6/28/19
Potential Completion Date
6/30/20
Potential Value
$202K
Federal Agency
NIH Clinical Center
Awardee
Origen Biomedical, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78744, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Origene Technologies, Inc. The contract is for the provision of "HIGH AFFINITY SISCAPA ANTIBODIES" and was awarded on September 25, 2013 with a ceiling value of $199,996.00. The contract is a definitive, firm fixed-price contract with a completion date of November 24, 2014. No set-aside designation was used for this award. Origene Technologies,...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Mental Health to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $118,320.00 contract is for the purchase of assorted cell culture medium, substrate, and supplements, with a completion date of December 13, 2018. The procurement did not utilize any set-aside designations. As a...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a firm-fixed-price purchase order to Saint-Gobain Performance Plastics Corporation, doing business as Saint-Gobain Performance Plastics Corp, to procure sterile bags and non-sterile pouches used for cryopreservation of cellular therapy products. The $249,931.75 contract has a completion date of September 15, 2023. Saint-Gobain, a manufacturer of goods, is providing these specialized medical devices,...
This is a $25,000.00 firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation for the standing order of cell culture reagents. The award is not associated with a set-aside and has an ultimate completion date of August 13, 2025. As a manufacturer of scientific instruments, reagents, and consumables, Life Technologies provides a wide...
<p>This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Invivogen, a for-profit organization, for the delivery of biological and reagent materials. The contract has a ceiling value of $12,992.70 and a period of performance ending on March 3, 2026. This contract is not associated with a larger vehicle and does not have a set-aside designation. The NHGRI is the funding agency for this contract.</p>
This is a $15,150 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Origene Technologies, Inc. for cDNA sequencing services. The contract was awarded without any set-aside and has a completion date of September 10, 2014. Origene Technologies, Inc. is a for-profit organization that provides a range of life science research products and services, including cDNA clones, antibodies, and assays. Through prior prime contracts with the...
This is a $983,105.58 definitive contract awarded by the National Cancer Institute (NCI) to Origene Technologies, Inc. to provide "HIGH AFFINITY SISCAPA ANTIBODIES". The contract is a cost-no-fee arrangement with a completion date of September 21, 2018. Origene Technologies is a for-profit organization that specializes in providing research reagents such as cDNA clones, antibodies, and proteins to government agencies, including the Department of Veterans Affairs. While no set-aside was...
This is a firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian federal agency, to Capital Biosciences, Inc. for "CUSTOM CELL IMMORTALIZATION FOR MARVIN GERSHENGORN, QUOTE: 9429". The contract has a ceiling value of $13,445.00 and an ultimate completion date of October 1, 2010. There is no set-aside designation for this award. The contract provides for the delivery of custom cell immortalization services to...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center, a civilian federal agency, to Biolife Solutions, Inc., a for-profit company based in Bothell, Washington. The contract is for the supply of 100 milliliter bags of the company's CryoStor CS10 cryopreservation reagent, a critical component in the preservation and handling of cellular materials used in medical research and therapeutic applications. The contract has a ceiling...
This is a firm-fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Mimetas Operations US, CO. for 25 units of the Organoplate Graft (part number 6401-400-B), a microfluidic 3D cell culture plate used in research related to SARS-CoV-2 and COVID-19. The $29,075.00 contract was awarded on a sole-source, non-competitive basis due to...